NCI and COG initiate paediatric Phase II trial for precision cancer drugs

The National Institutes of Health ’s (NIH) unit National Cancer Institute (NCI) and the Children’s Oncology Group (COG) have initiated patient enrolment in a paediatric Phase II clinical trial to evaluate targeted cancer medicines.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news